Protherics PLC Notification of Major Interests in Shares London, UK; Brentwood, TN, US: 30 October 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that on 29 October 2007, in accordance with the Transparency Obligations Directive, a notification of interest in the ordinary share capital of the Company was received from AXA Investment Managers UK Limited on behalf of AXA S.A. and its Group Companies ("AXA"). The notification follows a decrease in the Indirect holding of AXA. Details of the interest notified are as follows: 1. Reason for the notification (please tick the appropriate box or boxes) A disposal of voting rights X An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): 2. Full name of person(s) subject to the AXA S.A., 25 Avenue Matignon, 75008 Paris and its notification obligation: group of companies. 3. Full name of shareholder(s) (if different from 2.): 4. Date of the transaction (and date on which 28 October 2007 the threshold is crossed or reached if different): 5. Date on which issuer notified: 29 October 2007 6. Threshold(s) that is/are crossed or reached: 12% 7. Notified details: A: Voting rights attached to shares Class/type of Situation previous to Resulting situation after the triggering transaction shares the Triggering transaction if possible using Number of Number of Number of Number of voting rights % of voting rights the ISIN CODE Shares Voting shares Rights Direct Direct Indirect Direct Indirect 0702920 41,502,097 41,502,097 741,666 741,666 40,684,681 0.22% 11.99% B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting rights instrument Period/ Date that may be acquired if the instrument is exercised/ converted. Total (A+B) Number of voting rights % of voting rights 41,426,347 12.21% 8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable : Name of Company/Fund Number of Shares % of issued share capital AXA UK Investment Co ICVC 527,152 0.15534 UK Smaller Companies Fund Indirect Sun Life Pensions Management Ltd 25,000 0.00737 Direct AXA Sun Life 53,913 0.01589 FTSE All Share Tracker Life Direct AXA Sun Life 294,874 0.08689 FTSE All Share Tracker Pension Direct AXA Framlington 750,000 0.22101 SEI UK Equity Indirect AXA Framlington 854,587 0.25183 St James Place Exempt (Pens) Fund Indirect AXA Framlington 961,409 0.28331 St James Place Net (Life) Fund Indirect AXA Framlington 213,646 0.06296 St James Place Offshore Fund Indirect AXA Framlington 320,470 0.09444 Daimler Chrysler Indirect AXA Framlington 3,120,333 0.91951 Throgmorton Trust Indirect AXA Framlington 15,013,453 4.42422 UK Selet Ops Indirect AXA Framlington 13,753,131 4.05282 Equity Income Indirect AXA Framlington 2,000,000 0.58937 Managed Balanced Indirect AXA Framlington 1,500,000 0.44203 UK Smaller Companies Indirect AXA Framlington 500,000 0.14734 BAE Systems Pensions Fund CIF Trustees Indirect AXA Framlington 220,000 0.06483 BAE Systems 2000 Pensions Fund Indirect AXA Framlington onshore private clients 850,500 0.25063 Indirect AXA Sun Life plc 226,817 0.06684 With Profit Transition Fund Direct Sun Life Assurance Society plc 141,062 0.04157 With Profit Transition Fund Direct AXA Framlington 100,000 0.02947 ST James Place Internal Equity & Income UT Indirect Total Direct 741,666 0.21856 Total Indirect 40,684,681 11.98912 TOTAL 41,426,347 12.20767 Proxy Voting: 9. Name of the proxy holder: 10. Number of voting rights proxy holder will cease to hold: 11. Date on which proxy holder will cease to hold voting rights: 12. Additional information: | Ends | For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock Exchange
Protherics PLC announces Holding(s) in Company
| Source: Protherics PLC
Cheshire, UK--(Marketwire - October 30, 2007) -